CBOE · CLSE
Convergence Long/Short Equity ETF
$32.77-$0.39 (-1.18%)
Convergence Long/Short Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.
Loading market information…
AMEX · PBE · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Invesco Biotechnology & Genome ETF’s quoted price sits in the upper half of its reported 52-week range, 1.83% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Invesco Biotechnology & Genome ETF’s forward annual dividend is $0.07 per share, paid quarterly. The forward yield is 0.07% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 09:37 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$32.77-$0.39 (-1.18%)
Convergence Long/Short Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 5.72% below the high.
$78.61-$0.88 (-1.11%)
Avantis Responsible International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 6.32% below the high.
$87.60-$1.81 (-2.03%)
Janus Henderson Small Cap Growth Alpha ETF’s quoted price sits in the upper half of its reported 52-week range, 10.62% below the high.
$46.88-$0.64 (-1.35%)
Inspire Small/Mid Cap ETF’s quoted price sits in the upper half of its reported 52-week range, 9.11% below the high.
$71.94-$2.48 (-3.33%)
Dimensional - Emerging Markets ex China Core Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 17.0% below the high.
$55.55-$0.30 (-0.53%)
Invesco S&P 500 Equal Weight Consumer Discretionary ETF’s quoted price sits in the lower half of its reported 52-week range, 7.94% below the high.
$37.89-$0.44 (-1.14%)
NYLI Candriam International Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 4.39% below the high.
$31.53+$0.42 (+1.35%)
Invesco S&P 500 Equal Weight Consumer Staples ETF’s quoted price sits in the upper half of its reported 52-week range, 5.51% below the high.
